Find comprehensive information on coding and documenting a history of malignant melanoma. This resource covers clinical documentation requirements, ICD-10 codes (C43, Z85.82), melanoma staging, SNOMED CT concepts, and best practices for accurate medical record keeping related to a patient's past diagnosis of melanoma. Learn about appropriate terminology for healthcare professionals, including physicians, nurses, and medical coders, to ensure proper diagnosis reporting and care management for patients with a history of malignant melanoma.
Also known as
Personal history of malignant melanoma
Personal history of melanoma of skin.
Malignant melanoma, unspecified
Melanoma of skin, unspecified site, if used with Z85.820
Other malignant neoplasm of skin
Other specified melanomas, to be used with Z85.820
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the melanoma currently active?
When to use each related code
Description |
---|
Malignant Melanoma |
Atypical Melanocytic Nevus |
Melanoma in situ |
Coding Z85.82 without specifying the original melanoma site if known creates documentation and billing risks.
Incorrectly coding active melanoma (C43.-) instead of history (Z85.82) leads to overcoding and compliance issues.
Miscoding melanoma in situ (D03.90) as history of invasive melanoma can impact quality reporting and reimbursement.
Patient presents with a history of malignant melanoma. Initial diagnosis date was documented as [Date of Initial Diagnosis]. The primary site of the original melanoma was [Location of Primary Melanoma] with a Breslow thickness of [Breslow Thickness] mm, Clark level [Clark Level], and [Presence or Absence] of ulceration. [Positive or Negative] sentinel lymph node biopsy was performed on [Date of Sentinel Node Biopsy], revealing [Number] positive nodes out of [Total Number] examined. The original melanoma was staged as [Stage of Melanoma] according to the AJCC staging system. Treatment for the initial melanoma included [Treatment Modalities, e.g., wide local excision, sentinel lymph node biopsy, adjuvant therapy]. The patient is currently [Asymptomatic or Symptomatic] with [Description of Current Symptoms, if any]. Physical examination revealed [Findings on Physical Exam, including any suspicious lesions with size, color, and location]. Patient reports [Patient-reported concerns or symptoms related to potential recurrence]. Differential diagnoses considered include [Differential Diagnoses]. Plan includes [Plan of Care, e.g., full skin examination, imaging studies, biopsy, referral to oncology]. Melanoma recurrence, skin cancer screening, dermatologic oncology, and sentinel lymph node mapping were discussed with the patient. Patient education provided on sun protection and skin self-examination. Follow-up scheduled in [Follow-up Interval].